A mechanism of resistance to TRAIL/Apo2L-induced apoptosis of newly established glioma cell line and sensitisation to TRAIL by genotoxic agents
2003

Overcoming Resistance to TRAIL in Glioma Cells

publication 10 minutes Evidence: moderate

Author Information

Author(s): Y Arizono, H Yoshikawa, H Naganuma, Y Hamada, Y Nakajima, K Tasaka

Primary Institution: Yamanashi Medical University

Hypothesis

Can genotoxic agents sensitize TRAIL-resistant glioma cells to apoptosis?

Conclusion

Genotoxic agents can restore TRAIL receptor expression in glioma cells, making them sensitive to TRAIL-induced apoptosis.

Supporting Evidence

  • TRAIL can induce apoptosis in many tumor cells but not in normal cells.
  • The #63 glioma cell line completely lacks TRAIL receptors.
  • Genotoxic agents can induce the expression of TRAIL-R2 in resistant glioma cells.
  • Combination treatment with TRAIL and genotoxic agents enhances cell death.
  • Wild-type p53 is important for the expression of TRAIL receptors.

Takeaway

Some cancer cells are hard to kill, but using certain drugs can help make them more vulnerable to treatment.

Methodology

The study involved establishing a TRAIL-resistant glioma cell line and testing the effects of TRAIL combined with genotoxic agents on cell viability.

Potential Biases

Potential bias in the selection of cell lines and reagents used in the experiments.

Limitations

The study primarily focused on one glioma cell line, which may limit the generalizability of the findings.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1038/sj.bjc.6600666

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication